MoneyWorks4Me

Mankind Pharma informs about certificate

10 Jul 2026 Evaluate
Pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, Mankind Pharmahas informed that it enclosed a copy of the certificate received from KFin Technologies, the Registrar and Share Transfer Agent of the Company for the quarter ended on June 30, 2026. 

The above information is a part of company’s filings submitted to BSE.

Mankind Pharma Share Price

2390.00 -9.95 (-0.41%)
18-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1876.40
Dr. Reddys Labs. 1180.50
Cipla 1431.85
Lupin 2225.00
Zydus Lifesciences 1117.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: